Показано 0 из 0
Дата |
---|
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
2.42
|
2.56
|
2.42
|
2.4101
|
2.57
|
2.54
|
|
|
205 776.99
|
795.00
|
2.31
|
2.63
|
2.40
|
2.377
|
2.49
|
2.40
|
|
|
141 167.71
|
882.00
|
2.15
|
2.45
|
2.39
|
2.36
|
2.445
|
2.40
|
|
|
218 549.60
|
852.00
|
2.36
|
2.45
|
2.34
|
2.34
|
2.44
|
2.37
|
|
|
162 771.85
|
774.00
|
2.15
|
2.39
|
2.30
|
2.20
|
2.37
|
2.32
|
|
|
278 049.58
|
1 082.00
|
2.29
|
2.36
|
2.39
|
2.28
|
2.40
|
2.28
|
|
|
416 323.05
|
1 032.00
|
2.37
|
2.44
|
2.39
|
2.39
|
2.44
|
2.40
|
|
|
108 042.40
|
345.00
|
2.36
|
2.63
|
2.36
|
2.31
|
2.42
|
2.37
|
|
|
197 549.43
|
640.00
|
2.32
|
2.60
|
2.49
|
2.36
|
2.496
|
2.36
|
|
|
278 584.56
|
1 177.00
|
2.39
|
2.45
|
2.48
|
2.40
|
2.48
|
2.47
|
|
|
248 203.84
|
697.00
|
AN2 Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. AN2 Therapeutics serves customers worldwide.